In vivo assessment of temozolomide local delivery for lung cancer inhalation therapy

European Journal of Pharmaceutical Sciences

Volumn 39, Issue 5, 2010, Pages 402-411

  Wauthoz, Nathalie ^a   Deleuze, Philippe ^a   Hecq, Julien ^a   Roland, Isabelle ^b   Saussez, Sven ^c   Adanja, Ivan ^a   Debeir, Olivier ^a   Decaestecker, Christine ^a   Mathieu, Véronique ^a   Kiss, Robert ^a   Amighi, Karim ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c UNIVERSITY OF MONS   (Belgium)

Author keywords

Aerosol therapy; Fluorescent microparticles; Lung pseudo metastases; Mouse B16F10 melanoma; NSCLC; Temozolomide

Indexed keywords

TEMOZOLOMIDE;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG STABILITY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG METASTASIS; LUNG TUMOR; MAXIMUM TOLERATED DOSE; MELANOMA; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PSEUDOTUMOR; REPRODUCIBILITY; SUSPENSION;

ADMINISTRATION, INHALATION; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DACARBAZINE; FEMALE; FLUORESCENT DYES; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS;

EID: 77549084017     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.01.010     Document Type: Article

References (51)

1. Amorij J.-P., Saluja V., Petersen A.H., Hinrichs W.L.J., Huckriede A., and Frijlink H.W. Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune response in BALB/c mice. Vaccine 25 (2007) 8707-8717
2. Anabousi S., Bakowsky U., Schneider M., Huwer H., Lehr C.M., and Ehrhardt C. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer. Eur. J. Pharm. Sci. 29 (2006) 367-374
3. Atkins P.J., and Crowder T.M. The design and development of inhalation drug delivery systems. In: Hickey A.J. (Ed). Pharmaceutical Inhalation Aerosol Technology (2004), Marcel Dekker, New York 279-309
4. Bivas-Benita M., Zweir R., Junginger H.E., and Borchard G. Non-invasive pulmonary aerosol delivery in mice by the endotracheal route. Eur. J. Pharm. Biopharm. 61 (2005) 214-218
5. Burris H.A. Shortcoming of current therapies for non-small-cell lung cancer: unmet medical needs. Oncogene 28 Suppl. 1 (2009) S4-S13
6. Carballo M., Maish M.S., Jaroszewski D.E., and Holmes C.E. Video-assisted thoracic surgery (VATS) as a safe alternative for the resection of pulmonary metastases: a retrospective cohort study. J. Cardiothorac. Surg. 4 (2009) 13
7. 2: a potential small-molecule single-photon emission computed tomography probe for imaging metastatic melanoma. Cancer Res. 65 (2005) 4979-4986
8. Choong N.W., Mauer A.M., Hoffman P.C., Rudin C.M., Winegarden J.D., Villano J.L., Kozloff M., Wade J.L., Sciortino D.F., Szeto L., and Vokes E.E. Phase II trial of temozolomide and irinotecan as second line treatment for advanced non-small cell lung cancer. J. Thorac. Oncol. 1 (2006) 732-733
9. Chung K.F., Caramori G., and Adcock I.M. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur. J. Clin. Pharmacol. 65 (2009) 853-871
10. Dario A., and Tomei G. The safety of the temozolomide in patients with malignant glioma. Curr. Drug Saf. 1 (2006) 205-222
11. Darro F., Decaestecker C., Gaussin J.F., Mortier S., Van Ginckel R., and Kiss R. Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?. Int. J. Oncol. 27 (2005) 607-616
12. Davies N.M., and Feddah M.R. A novel method for assessing dissolution of aerosol inhaler products. Int. J. Pharm. 255 (2003) 175-187
13. Delepine P., Montier T., Guillaume C., Vaysse L., LePape A., and Ferec C. Visualization of the transgene distribution according to the administration route allows prediction of the transfection efficacy and validation of the results obtained. Gene Ther. 9 (2002) 736-739
14. Dennett J.A., Stark P.M., Vessey N.Y., Parsons R.E., and Bueno Jr. R. Estimation of aerosol droplet sizes by using a modified DC-III portable droplet measurement system under laboratory and field conditions. J. Am. Mosq. Control Assoc. 22 (2006) 707-717
15. Dougherty E.R., and Lotufo R.A. Hands-on Morphological Image Processing (2003), Spie Press, Washington
16. Driscoll K.E., Costa D.L., Hatch G., Henderson R., Oberdorster G., Salem H., and Schlesinger R.B. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol. Sci. 55 (2000) 24-35
17. Gagnadoux F., Hureaux J., Vecellio L., Urban T., Le Pape A., Valo I., Montharu J., Leblond V., Boisdron-celle M., Lerondel S., Majoral C., Diot P., Racineux J.L., and Lemarie E. Aerosolized chemotherapy. J. Aerosol Med. Pulm. Drug Deliv. 21 (2008) 61-69
18. Gagnadoux F., Pape A.L., Lemarie E., Lerondel S., Valo I., Leblond V., Racineux J.-L., and Urban T. Aerosol delivery of chemotherapy in an orthotopic model of lung cancer. Eur. Respir. J. 26 (2005) 657-661
19. Gautam A., Densmore C.L., Melton S., Golunski E., and Waldrep J.C. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis. Cancer Gene Ther. 9 (2002) 28-36
20. Gerber D.E., Grossman S.A., Zeltman M., Parisi M.A., and Kleinberg L. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro-oncology 9 (2007) 47-52
21. Hecq J., Deleers M., Fanara D., Vranckx H., and Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int. J. Pharm. 299 (2005) 167-177
22. Hildebrandt M., Gu J., and Xifeng W. Pharmacogenomics of platinum-based chemotherapy in NSCLC. Expert Opin. Drug Metab. Toxicol. 5 (2009) 745-755
23. Ingrassia I., Lefranc F., Dewelle J., Pottier L., Mathieu V., Spiegl-Kreinecker S., Sauvage S., El Yazidi M., Dehoux M., Berger W., Van Quaquebeke E., and Kiss R. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J. Med. Chem. 52 (2009) 1100-1114
24. Jain K.K. Drug delivery systems-an overview. Methods Mol. Biol. 437 (2008) 1-50
25. Knight V., Koshkina N.V., Waldrep J.C., Giovanella B.C., and Gilbert B.E. Anticancer effect of 9-nitrocamptothecin liposome aerosol on human cancer xenografts in nude mice. Cancer Chemother. Pharmacol. 44 (1999) 177-186
26. Koshkina N.V., Kleinerman E.S., Waldrep J.C., Jia S.F.J., Worth L.L., Gilbert B.E., and Knight V. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin. Cancer Res. 6 (2000) 2876-2880
27. Koshkina N.V., Waldrep J.C., Roberts L.E., Golunski E., Melton S., and Knight V. Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model. Clin. Cancer Res. 7 (2001) 3258-3262
28. Kouroussis C., Vamvakas L., Vardakis N., Ktsakis A., Kalykaki A., Kalbakis K., Saridakis Z., Kentepozidis N., Giassas S., and Georgoulias V. Continuous administration of daily low-dose temozolomide in pretreated patients with advanced non-small cell lung cancer: a phase II study. Oncology 76 (2009) 112-117
29. Krug S., Sablotzki A., Hammerschmidt S., Wirtz H., and Seyfarth H.J. Inhaled iloprost for the control of pulmonary hypertension. Vasc. Health Risk Manage. 5 (2009) 465-474
30. Lefranc F., Facchini V., and Kiss R. Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12 (2007) 1395-1403
31. Lefranc F., Rynkowski M., DeWitte O., and Kiss R. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv. Tech. Stand. Neurosurg. 34 (2009) 3-35
32. Mathieu V., Le Mercier M., De Neve N., Sauvage S., Gras T., Roland I., Lefranc F., and Kiss R. Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model. J. Invest. Dermatol. 127 (2007) 2399-2410
33. Onaitis M.W., Petersen R.P., Haney J.C., Saltz L., Park B., Flores R., Rizk N., Bains M.S., Dycoco J., D'Amico T.A., Harpole D.H., Kemeny N., Rusch V.W., and Downey R. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann. Thorac. Surg. 87 (2009) 1684-1688
34. Pawar R., Shikanov A., Vaisman B., and Domb A.J. Intravenous and regional paclitaxel formulations. Curr. Med. Chem. 11 (2004) 397-402
35. Pilcer G., Sebti T., and Amighi K. Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation. Pharm. Res. 23 (2006) 931-940
36. Ricciardi S., Tomao S., and de Marinis F. Toxicity of targeted therapy in non-small-cell lung cancer management. Clin. Lung Cancer 10 (2009) 28-35
37. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug Deliv. Rev. 58 (2006) 1030-1060
38. Salama R.O., Daniela T., Chan H.K., and Young P.M. Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur. J. Pharm. Biopharm. 70 (2008) 145-152
39. Sampson J.H., Archer G.E., Villavicencio A.T., McLendon R.E., Friedman A.H., Bishop W.R., Bigner D.D., and Friedman H.S. Treatment of neoplastic meningitis with intrathecal temozolomide. Clin. Cancer Res. 5 (1999) 1183-1188
40. Sandeep N., Brendel R.J., and Washkuhn R.J. Excipients-their role in parenteral dosage forms. In: Swarbrick J., and Boylan J.C. (Eds). Encyclopedia of Pharmaceutical Technology, vol. 2. second edition (2002), Marcel Dekker, New York 1165-1187
41. Sebti T., and Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur. J. Pharm. Biopharm. 63 (2006) 51-58
42. Shen F., Decosterd L.A., Gander M., Leyvraz S., Biollaz J., and Lejeune F. Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction. J. Chromatogr. B 667 (1995) 291-300
43. Smyth H.D.C., Saleem I., Donovan M., and Verschraegen C.F. Pulmonary delivery of anti-cancer agents. In: Williams R.O., Taft D.R., and McConville J.T. (Eds). Advanced Drug Formulation Design to Optimize Therapeutic Outcomes (2008), Informa Healthcare, New York 81-111
44. Son Y.J., and McConville J.T. Development of a standardized dissolution test method for inhaled pharmaceutical formulations. Int. J. Pharm. 382 (2009) 15-22
45. Tamaskar I., Mekhail T., Dreicer R., Olencki T., Roman S., Elson P., and Bukowski R.M. Phase I trial of weekly docetaxel and daily temozolomide in patients with metastatic disease. Invest. New Drugs 26 (2008) 553-559
46. Tiseo M., Bartolotti M., Gelsomino F., and Ardizzoni A. First-line treatment in advanced non-small-cell lung cancer: the emerging role of the histologic subtype. Expert Rev. Anticancer Ther. 9 (2009) 425-435
47. Traini D., and Young P.M. Delivery of antibiotics to the respiratory tract: an update. Expert Opin. Drug Deliv. 6 (2009) 897-905
48. Van Quaquebeke E., Mahieu T., Dumont P., Dewelle J., Ribaucour F., Simon G., Sauvage S., Gaussin J.F., Tutti J., El Yazidi M., Van Vynckt F., Mijatovic T., Lefranc F., Darro F., and Kiss R. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-5-yl}carbamoyl)acetamide (UNBS 53157), a novel non hematotoxic naphthalimide derivative with potent antitumor activity. J. Med. Chem. 50 (2007) 4122-4134
49. Vincent M.D. Optimizing the management of advanced non-small-cell lung cancer: a personal view. Curr. Oncol. 16 (2009) 9-21
50. Yano T., Shoji F., and Maehara Y. Current status of pulmonary metastasectomy from primary epithelial tumors. Surg. Today 39 (2009) 91-97
51. Zou Y., Fu H., Ghosh S., Farquhar D., and Klostergaard J. Antitumor activity of hydrophilic paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Clin. Cancer Res. 10 (2004) 7382-7391